A phase 2 a, randomized open label study to evaluate the efficacy, safety tolerability, pharmocokinetics and pharmacodynamics of ISIS 702843 Administered subcutaneously to patients with non-transfusion depenmdent B- thalassemia intermedia | AVESİS

İstanbul Üniversitesi Akademik Veri Yönetim Sistemi

A phase 2 a, randomized open label study to evaluate the efficacy, safety tolerability, pharmocokinetics and pharmacodynamics of ISIS 702843 Administered subcutaneously to patients with non-transfusion depenmdent B- thalassemia intermedia

Karakaş Z. (Yürütücü), Tanyıldız H. G.

Diğer Uluslararası Fon Programları, 2021 - 2023

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Nisan 2021
Bitiş Tarihi: Nisan 2023